subgroups

Related by string. subgroup . Subgroup . Subgroups * * subgroup analyzes . demographic subgroups . Bayer HealthCare subgroup . subgroups Bayer HealthCare . Subgroup analysis . Subgroup analyzes . economically disadvantaged subgroup . Subgroup Analysis . discrete subgroups . economically disadvantaged subgroups *

Related by context. All words. (Click for frequent words.) 79 subgroup 69 Subgroups 68 demographic subgroups 67 subpopulations 62 subsets 59 economically disadvantaged subgroups 59 economically disadvantaged subgroup 57 AYP benchmarks 57 socioeconomically disadvantaged 57 subpopulation 57 Economically disadvantaged students 56 AYP 54 ethnicity socioeconomic status 53 subtests 52 socio economically disadvantaged 52 sociodemographic 51 subcategories 51 Adequate Yearly Progress 51 deciles 51 Adequate Yearly Progress AYP 51 Baseline characteristics 51 adequate yearly 50 socioeconomic status 50 tertile 50 English Language Learners 50 Economically Disadvantaged 50 prospectively defined 50 language learners 50 Academic Yearly Progress 50 prognostic factors 50 quintiles 50 economically disadvantaged 49 socioeconomic backgrounds 49 subgroup analyzes 49 confounding variables 49 quartiles 49 docetaxel pretreated 49 Annual Yearly Progress 49 reach statistical significance 49 multivariate analyzes 49 Average Yearly Progress 49 non squamous histology 49 histological subtypes 49 prespecified 48 subsamples 48 tertiles 48 socioeconomically disadvantaged students 48 DAS# scores 48 subset 48 ethnically diverse populations 48 secondary efficacy endpoints 48 System IPSS 48 SDAA II 48 math proficiency 48 Sampling error 48 BMI z 47 covariates 47 pharmacodynamic parameters 47 comorbidities 47 socioeconomic variables 47 socioeconomic strata 47 hemoglobin A1c levels 47 cognitive domains 47 Subgroup analyzes 47 histologies 47 socioeconomic statuses 47 PSAE 47 subscales 47 allele frequencies 47 subregions 47 CSAP scores 47 MMSE scores 47 liver transplant recipients 47 populations 47 bivariate analyzes 47 baseline HbA1c 47 lipid parameters 47 Maori Pasifika 47 completely resected 47 familial clustering 46 hepatitis C genotype 46 osteopenic 46 MEAP tests 46 adverse cytogenetics 46 subtypes 46 HbA 1c 46 racially identifiable 46 HbA 1C 46 GHSGT 46 socioeconomic characteristics 46 histologic subtype 46 histological subtype 46 WASL scores 46 Ashworth Scale 46 NECAP scores 46 sociodemographic factors 46 baseline LDH 46 Multivariate analysis 46 secondary endpoints 46 prognostic variables 46 exploratory endpoints 46 MADIT CRT trial 46 prevalences 46 MEAP scores 45 socioeconomic disparities 45 unpaired t 45 ISAT scores 45 metabolic parameters 45 NNRTI resistance 45 ELLs 45 HbA 1c levels 45 census tracts 45 racial disparities persist 45 Algebra I. 45 clades 45 neurocognitive functioning 45 undetectable HBV DNA 45 susceptibility loci 45 geographic regions 45 histologic subtypes 45 cTnT levels 45 serum calcium 45 molecular subtypes 45 Cognitive Abilities Test 45 protease inhibitor mutations 45 College Readiness Benchmarks 45 demographic variables 45 etiologies 45 tumor histology 45 IPAH 45 unfavorable cytogenetics 45 HIV HCV coinfected 45 AZ Learns 45 statistically significant 45 Adequate yearly 45 Districtwide 45 mITT 45 socioeconomic status SES 45 sociodemographic variables 45 telomere lengths 45 perioperative complications 45 alanine aminotransferase ALT 45 systolic blood pressures 45 strongest predictors 45 nonresponders 45 A1Cs 45 bivariate 45 CORE OM 45 univariate analyzes 45 TAKS scores 45 Indians Alaska Natives 45 baseline A1C 45 SNP rs# [002] 45 clinicopathologic 45 pharmacodynamic endpoints 45 visceral metastases 45 categories 45 confounders 45 Asian Pacific Islander 44 hypertensives 44 randomized trials 44 infarcts 44 potential confounders 44 obstructive coronary artery 44 primary endpoints 44 MetS 44 squamous histology 44 ISTEP + exam 44 MMSE score 44 Univariate analysis 44 NHANES III 44 statistically significant differences 44 TEAEs 44 coronary stenosis 44 HRQL 44 seminomas 44 slow metabolizers 44 Advanced Proficient 44 chromosomal alterations 44 socioeconomic 44 microbiologically evaluable 44 Longitudinal studies 44 nonvertebral fractures 44 carotid plaque 44 creatinine levels 44 enterotypes 44 CCyR 44 fibrosis progression 44 predefined criteria 44 HER2 expression 44 cross sectionally 44 fasting insulin 44 ANOVA 44 EGFR mutations 44 HbA1C levels 44 logistic regression analyzes 44 elevated LDH 44 Charlson comorbidity index 44 systolic dysfunction 44 DSM IV SCID 44 cohort 44 EDNOS 44 BMI percentiles 44 liver histology 44 virologic failure 44 LVEF 44 Native Hawaiian Pacific Islander 44 patient subpopulations 44 heavily pretreated 44 dosing cohorts 44 adjuvant therapies 44 PREZISTA r arm 44 psychosocial functioning 44 statistical significance 44 regression analyzes 44 nondiabetic patients 44 HbA1c levels 44 glycated hemoglobin 44 nonsignificant 44 Hb A1C 44 neoplasias 44 HPV genotypes 44 ISTEP + 44 NAEP scores 44 serum creatinine levels 44 CSAP tests 44 virologic response 44 coinfected 44 suicide attempters 44 PISA exam 44 ethnicities 44 Complication rates 44 correlation coefficients 44 classifications 44 SORT OUT III 43 sustained virologic response 43 breast carcinomas 43 A1c levels 43 elevated triglyceride levels 43 dropout rates 43 artery elasticity 43 comorbid conditions 43 elevated triglycerides 43 sustained virological response 43 receiving Vectibix monotherapy 43 decompensated liver disease 43 waist circumferences 43 Bonferroni correction 43 syndromal 43 abnormal cytology 43 morbidities 43 HAQ DI 43 dosing regimens 43 generalizability 43 prognostically 43 baseline CD4 43 cystatin C 43 schizophreniform disorder 43 nondiabetic 43 stratifying patients 43 ANCOVA 43 chromosomal regions 43 hydroxyvitamin D levels 43 ELA exam 43 Patient Populations 43 psychiatric comorbidities 43 Shayma Ahmed 43 HSCT 43 CSAP 43 Genotypes 43 evaluable 43 HBeAg negative patients 43 attain statistical significance 43 KRAS mutation 43 APOE genotype 43 Graduation Qualifying Exam 43 interracial friendships 43 AZ LEARNS 43 Competency Tests 43 TT genotype 43 GQE 43 efficacy endpoints 43 psychiatric comorbidity 43 hypertension hypercholesterolemia 43 Hispanic whites 43 criterion referenced 43 inflammatory biomarkers 43 genetic determinants 43 statistically nonsignificant 43 CELDT 43 achieved sustained virological 43 chromosome #q#.# [001] 43 CRCT scores 43 racially imbalanced 43 A1C levels 43 nationally normed 43 squamous 43 NYHA functional class 43 meta analyzes 43 univariate 43 Personality disorders 43 poor metabolizers 43 hsCRP levels 43 demographic characteristics 43 WOMAC pain 43 efficacy endpoint 43 hormone receptor negative 43 subtest 43 interindividual variability 43 breast cancer susceptibility genes 43 DAS# [002] 43 MADRS score 43 missense mutations 43 thromboembolic complications 43 Commended Performance 43 covariate 43 hippocampal volumes 43 haplotypes 43 developmental trajectories 43 dose regimens 43 umol L 43 IEPs 43 causative mutation 43 KRAS mutations 43 Criterion Referenced Competency Tests 43 epithelial tumors 43 morphometric vertebral fractures 43 Multivariate analyzes 43 MGUS 43 Socioeconomic status 43 histologically confirmed 43 EOCT 43 Confidence Interval 43 nonobese 43 ALLHAT 43 oral antidiabetic agents 43 REYATAZ r arm 43 thyrotropin levels 43 underwent CABG 43 urodynamic parameters 43 PNH patients 43 Kaplan Meier curves 43 Graduation Exit Exam 43 dietary patterns 43 genotypic resistance 43 LTBI 43 HbA1C 42 hemoglobin concentrations 42 platelet reactivity 42 prostate cancer CaP 42 antithrombotic agents 42 univariate analysis 42 MCA IIs 42 EGFR mutation status 42 NYHA class 42 segments 42 ELL 42 urate levels 42 circulating endothelial cells 42 English proficiency 42 lipid elevations 42 breast cancer subtypes 42 MCAS scores 42 antibody titer 42 clinicopathological 42 apolipoprotein B 42 subscores 42 lipid profiles 42 statistically significant correlations 42 nonfatal cardiac arrest 42 fasting glucose 42 adenocarcinoma histology 42 hyperhomocysteinemia 42 diastolic blood pressures 42 antihypertensive agents 42 GCSE attainment 42 highest quintile 42 NIHSS 42 Meta analyzes 42 coinfection 42 virologic responses 42 CRCTs 42 severe periodontitis 42 AYP Adequate Yearly Progress 42 Crohn Disease Activity 42 racial minorities 42 recurrent coronary 42 primary efficacy endpoints 42 SGAs 42 distinct subtypes 42 prespecified criteria 42 interobserver reliability 42 VADT 42 seronegative 42 LDL HDL 42 math TAKS 42 English proficiency LEP 42 cTnT 42 ejection fractions 42 KDOQI 42 LDL particle 42 highest tertile 42 dosage regimens 42 ISTEP 42 toxins menthol cigarettes 42 comorbidity 42 logistic regression models 42 symptomatic intracerebral hemorrhage 42 Educational Progress Plus 42 prognostic indicators 42 percentages 42 histologic 42 Caucasians 42 clade B 42 CAPT scores 42 waist girth 42 CTEPH 42 ertapenem 42 retrospective cohort 42 TAKS tests 42 metabolically healthy 42 MACCE 42 dose cohorts 42 Stage IIIb 42 NYHA 42 longitudinal studies 42 hepatocellular carcinomas 42 UPDRS motor 42 hereditary predisposition 42 International Prognostic Scoring 42 p = .# [002] 42 neutrophil counts 42 HAM D 42 anti JCV antibodies 42 Caucasian descent 42 noninferiority 42 subclinical atherosclerosis 42 prespecified secondary 42 NHANES surveys 42 Among 42 multivariate regression analysis 42 HRQoL 42 randomized controlled trials RCTs 42 VTE prophylaxis 42 subsegments 42 glycoprotein IIb IIIa inhibitors 42 somatoform disorders 42 abdominal adiposity 42 lowest tertile 42 macrovascular events 42 HNSCC 42 odds ratios ORs 42 EDSS score 42 multivessel disease 42 AI AN 42 sociodemographic characteristics 42 ascending doses 42 coinfected patients 42 colesevelam 42 limiting generalizability 42 Montgomery Åsberg Depression 42 logistic regression analysis 42 tumor subtypes 42 metformin monotherapy 42 lymph node involvement 42 periprocedural MI 42 ERGs 42 MRSA isolates 42 multivariable analysis 42 troponin T 42 undergoing CABG 42 nonblack 42 p# biomarker 42 carotid plaques 42 serum cotinine levels 42 adenomatous polyps 42 Y BOCS 42 non inferiority 42 subscale scores 42 PERMP 42 histologically proven 42 genetic polymorphisms 42 Triglyceride levels 42 EGFR expression 42 serum concentrations 42 hormone receptor status 42 HBeAg negative 42 shorter telomere length 42 UBSCT 42 socioeconomic gradient 42 grade cervical intraepithelial 42 Disparities 42 NCEP ATP III 42 lowest quintile 42 SEER registry 42 abnormal lipids 42 hyper IgE syndrome 42 mineral density 42 EDSS scores 42 serum phosphate levels 42 lipid lowering medications 41 comorbid diagnoses 41 colorectal adenoma 41 laboratory abnormalities 41 molecularly defined 41 definite stent thrombosis 41 nonoperative treatment 41 groupings 41 GH deficiency 41 serum markers 41 CC genotype 41 subanalysis 41 clinically meaningful 41 echogenic foci 41 nondepressed 41 Connecticut Mastery Test 41 generalizable 41 posttransplant 41 microdeletion 41 efficacy evaluable 41 ISTEP + scores 41 modifiable lifestyle 41 papillary renal cell carcinoma 41 phenotypic characteristics 41 seroprotection 41 math CRCT 41 NIH CPSI 41 WKCE 41 esophageal squamous cell carcinoma 41 subclasses 41 dysglycemia 41 seroprevalence 41 thyroid nodules 41 CPAP adherence 41 convergent validity 41 dose cytarabine 41 HbA1c 41 BMI percentile 41 genotypes 41 Scale EDSS score 41 clinically evaluable 41 T2DM 41 FOLPI 41 statistical significance p 41 gastric carcinoma 41 density lipoprotein cholesterol 41 DSM IV diagnosis 41 p = #.# [003] 41 microbleeds 41 predictors 41 haematologic 41 subparts 41 virological response 41 HIV tropism 41 standardized tests 41 neurocognitive function 41 follicular lymphoma FL 41 comorbid disorders 41 precancerous polyp 41 narcolepsy cataplexy 41 axillary lymph nodes 41 ICSEA 41 PTEN gene 41 HCV genotype 41 timepoint 41 ECOG PS 41 subclinical hypothyroidism 41 advanced adenomas 41 euthymic 41 seroconversion 41 posttest 41 CLBP 41 malignant polyps 41 Dropout rates 41 differentially expressed genes 41 familial pancreatic cancer 41 arterial thickening 41 cryptogenic 41 psychosocial variables 41 achieved statistical significance 41 polyp recurrence 41 Brief Psychiatric 41 ACR Pedi 41 axillary lymph node 41 fasting serum 41 MDRD 41 patients evaluable 41 subcategory 41 elevated hsCRP 41 eplerenone 41 lipid lowering agents 41 hematopoietic cancers 41 homocysteine concentrations 41 Subgroup analysis 41 ECOG 41 latent tuberculosis infection 41 NECAP tests 41 educational attainments 41 antiretroviral naïve 41 nonadherent 41 multivariable adjusted 41 amnestic MCI 41 preoperative PSA 41 % CI #.#-#.# [004] 41 HOMA IR 41 hip BMD 41 tic severity 41 ConclusionThis 41 Depression Inventory 41 cotinine levels 41 dyslipidaemia 41 neuropsychological deficits 41 cytogenetic response 41 NJASK 41 T1a 41 nodal metastases 41 adiponectin concentrations 41 comorbid illnesses 41 tactile acuity 41 intravesical therapy 41 vertebral fracture 41 carcinoid 41 WOMAC scores 41 colorectal neoplasia 41 cytogenetic abnormalities 41 ethnicity 41 surrogate markers 41 Primary endpoints 41 cardiometabolic risk 41 locoregional recurrence 41 remission CR 41 hypoglycemic events 41 carotid stenosis 41 ISTEP exam 41 ISTEP scores 41 myocardial infarctions 41 paricalcitol 41 #q# deletion syndrome 41 co morbidities 41 Eleventh graders 41 susceptibility genes 41 metastatic lymph nodes 41 lymphoproliferative disorders 41 Gross Enrolment Ratio 41 composite endpoint 41 CAPRIE 41 ovarian carcinoma 41 SIMPADICO 41 nondemented 41 fructosamine 41 nonteaching hospitals 41 salivary cotinine 41 stratification 41 sUA 41 residual confounding 41 chronicity 41 lymph node metastases 41 multivariate analysis 41 benchmarks 41 observational cohort 41 CTBS 41 Education Plans IEPs 41 Alleles 41 linaclotide treated 41 spirometric 41 achieve statistical significance 41 MMSE 41 NAEP 41 nonsignificant difference 41 NAbs 41 revascularization procedures 41 hemoglobin concentration 41 Minnesota Comprehensive Assessments 41 ADAS cog 41 lung adenocarcinomas 41 generalisable 41 ischemic cardiomyopathy 41 K ras mutations 41 International Baccalaureate exams 41 etiologic 41 FDG PET imaging 41 immunodeficiencies 41 Colorectal cancer screening 41 symptomatic VTE 41 histopathologic 41 tirofiban 41 diameter stenosis 41 prognostic factor 41 posttreatment 41 CR nPR 41 gene expression profiles 41 acute myeloid leukemia AML 40 CHD mortality 40 nonfatal MI 40 myositis 40 NWEA MAP 40 causal pathways 40 randomized controlled trials 40 Non Hodgkin lymphomas 40 Bonferroni 40 ISTEP Plus scores 40 pharmacokinetic parameters 40 confounding factors 40 nonrepresentative 40 nonrandomized 40 Gram stain 40 underwent resection 40 TOP2A 40 TRITON TIMI 40 insulin glargine 40 HAI titers 40 HSAP 40 4CMenB 40 ADAS Cog 40 SGRQ 40 Hispanics Asians 40 myeloproliferative diseases 40 Dermatologic Toxicity Dermatologic toxicities 40 primary endpoint 40 subtyped 40 mean baseline A1C 40 meta analytic 40 SNPs pronounced snips 40 subsyndromal 40 Descriptive statistics 40 relapsing remitting 40 CLINICAL PHARMACOLOGY 40 EQ 5D 40 placebo controlled studies 40 ADHD RS 40 ICD therapy 40 metabolic abnormalities 40 dietary intakes 40 Hurthle cell 40 serum PSA 40 catagories 40 Scale EDSS 40 Neuroticism 40 visceral adiposity 40 adjuvant systemic 40 HPV subtypes 40 neurobiological disorders 40 ethnic backgrounds 40 districts 40 midstage study 40 macroalbuminuria 40 warfarin dose 40 rheumatoid factor 40 diastolic pressures 40 clinical endpoints 40 somatic symptoms 40 EGFR mutation positive 40 oligodendroglioma 40 virologically 40 NYHA Class II 40 Graduation Success 40 pressor response 40 serum selenium 40 hepatic cirrhosis 40 multivariate regression 40 bladder carcinoma 40 noncardiac 40 abnormal lipid levels 40 prophylactic cranial irradiation 40 hematologic toxicity 40 isolated systolic hypertension 40 structural abnormalities 40 secondary efficacy endpoint 40 grade gliomas 40 Individualized Education Plans 40 glycated hemoglobin levels 40 meningiomas 40 apnea hypopnea index 40 treated nonoperatively 40 autonomic dysfunction 40 haplogroups 40 BENICAR HCT 40 Index HAQ DI 40 GSTM1 40 Arts ELA 40 Montgomery Asberg Depression 40 English Language Learner 40 Disease Severity 40 NELS 40 groups 40 WESTEST 40 CNVs 40 Comorbidity 40 dosing cohort 40 nontasters 40 Secondary endpoints included 40 mcg albinterferon alfa 2b 40 MYH9 40 predictive validity 40 prior chemotherapy regimens 40 tigecycline 40 interrater reliability 40 aminotransferases 40 abdominal obesity 40 hematologic adverse 40 C1q 40 hsCRP 40 K ras mutation 40 serum phosphorous 40 CAHSEE 40 HER2 positive cancers 40 median survivals 40 multicenter trials 40 #mg/dL [001] 40 obstructive coronary 40 complete cytogenetic response 40 POAG 40 pT3 40 biopsy Gleason 40 serum GGT 40 leukopenia 40 confirmed CCyR 40 mean ± SEM 40 genetic loci 40 potentially confounding variables 40 phyla 40 RLS sufferers 40 diagnostically 40 chlorthalidone 40 ALT elevations 40 CIMZIA TM certolizumab pegol 40 atheroma volume 40 post hoc 40 heterozygous familial 40 Asian-American/Pacific Islander 40 serous ovarian cancer 40 Dulcan 40 DAS# CRP 40 Subgroup 40 CD4 lymphocytes 40 RECIST Response Evaluation Criteria 40 gene variants 40 lipoprotein particles 40 ITBS scores 40 CVD mortality 40 Approaching Basic 40 secondary endpoint 40 baseline serum creatinine 40 multivariate adjustment 40 S. aureus isolates 40 Health Assessment Questionnaire 40 antibody titers 40 echocardiographic parameters 40 pT2 40 elevated IOP 40 INTERHEART 40 CSAPs 40 astrocytomas 40 Immune responses 40 hemoglobin A1c 40 subsections 40 residual platelet reactivity 40 white matter hyperintensities 40 biochemical recurrence 40 anemia hemoglobin 40 MS DRGs 40 antihypertensive medications 40 estimated glomerular filtration 40 Medivation clinical trials 40 ascending dose 40 Individualized Education Programs 40 angiotensin converting enzyme inhibitors 40 serum potassium 40 meta analysis 40 precancers 40 dropout rate 40 antihypertensive drugs 40 transaminase elevations 40 internalizing disorders 40 PTEN mutations 40 strongest predictor 40 nonvertebral fracture 40 hypercoagulable 40 nonmelanoma 40 essential thrombocythemia 40 RECIST criteria 40 MPCP 40 NCLB mandates 40 thresholds 40 receiving golimumab 40 pretest probability 40 iron deficient 40 extensive metabolizers 40 standard deviations 40 serum cholesterol 40 intima media thickness IMT 40 plasma glucose concentration 40 incomplete revascularization 40 percentiles 40 carotid IMT 40 body habitus 40 neuropsychiatric symptoms 40 multiple logistic regression 40 proteinuria 40 trials RCTs 40 ethnicities genders 40 angiotensin II receptor blockers 40 renal cell carcinomas 40 hyperoxaluria 40 transaminase levels 40 DLQI 40 hemodialysis patients 40 CYP#C# genotype 40 ALT flares 40 hypertensive retinopathy 40 precursor lesions 40 LS BMD 40 intracranial hemorrhage ICH 40 non affective psychosis 40 ipsilateral breast 40 comorbid psychiatric disorders 40 evaluable subjects 40 colorectal polyp 40 UA NSTEMI 40 #q#.# deletion syndrome 40 socio demographic 40 orchitis 40 index BMI 40 treatment emergent AEs 40 microarray experiments 40 Median survival 40 B streptococcal 40 socioeconomically 40 supratentorial 40 polypoid lesions 40 FLT3 mutations 40 Adequate Yearly 40 nonoperative 40 fasting plasma 40 GRK5 40 intima media thickness 40 pituitary adenomas 40 fractional anisotropy 40 intelligence quotient IQ 40 hepatic fat 40 genotypic 40 individualizing instruction 40 ITBS 40 ISTEP Plus 40 APACHE II 40 folate concentrations 40 hemoglobin A1C 40 NHANES 40 chlamydial infection 40 socioeconomics 40 arterial thromboembolic events 40 monozygotic twins 40 pCR 40 grading rubric 40 adjuvant therapy 40 FDG PET scans 40 nonfatal stroke 40 adjuvant chemotherapy 40 NCLB 40 BCR ABL mutations 40 ISATs 40 haplotype 40 atherothrombotic disease 40 plasma folate 40 HDL cholesterol triglycerides 40 subclinical hyperthyroidism 40 serum cotinine 40 TIMI 40 serum IGF 40 HCV antibody 40 isotypes 40 etiologic factors 40 non hematological toxicities 40 English Proficient 40 Pacific Islander descent 40 PCNSL 40 adenocarcinomas 40 Observational studies 40 mechanistic studies 40 MCAS tests 40 methylation patterns 40 socio economically 40 Kaplan Meier curve 39 CLA supplementation 39 Connecticut Mastery Tests 39 immunostaining 39 juvenile idiopathic arthritis JIA 39 reactogenicity 39 Haptoglobin 39 cardiomyopathies 39 #q# deletion 39 Comprehensive Assessment Test 39 reverse transcriptase inhibitors 39 Thyroid nodules 39 cervical lymph nodes 39 genetic makeups 39 nonadherence 39 interindividual 39 Intervention Trial

Back to home page